Photronics Reports First Quarter Fiscal 2025 Results
“We achieved top-line results in line with our expectations and reflective of seasonal demand patterns,” said
First Quarter Fiscal 2025 Results
- Revenue was
$212.1 million , down 2% year-over-year and 5% sequentially. - GAAP Net income attributable to
Photronics, Inc. shareholders was$42.9 million , or$0.68 per diluted share, compared with$26.2 million , or$0.42 per diluted share, in the first quarter of 2024 and$33.9 million , or$0.54 per diluted share, in the fourth quarter of 2024. - Non-GAAP Net income attributable to
Photronics, Inc. shareholders was$32.4 million , or$0.52 per diluted share, compared with$29.9 million , or$0.48 per diluted share in the first quarter of 2024 and$37.1 million , or$0.59 per diluted share, in the fourth quarter of 2024. - IC revenue was
$154.0 million , down 2% year-over-year and 6% sequentially. - FPD revenue was
$58.1 million , down 1% from the same quarter last year and 1% sequentially. - Cash generated from operating activities was
$78.5 million , cash invested in organic growth through capital expenditures was$35.2 million , and cash returned to shareholders through share repurchases was$4.6 million . - Cash at the end of the quarter was
$642.2 million , and Debt was$2.7 million .
Second Quarter Fiscal 2025 Guidance
For the second quarter of fiscal 2025, Photronics expects Revenue to be between
Webcast
A webcast to discuss these results is scheduled for
About Photronics
Photronics is a leading worldwide manufacturer of integrated circuit (IC) and flat panel display (FPD) photomasks. High precision quartz plates that contain microscopic images of electronic circuits, photomasks are a key element in the IC and FPD manufacturing process. Founded in 1969, Photronics has been a trusted photomask supplier for over 55 years. The company operates 11 strategically located manufacturing facilities in
Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements” regarding our industry, our strategic position, and our financial and operating results. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, performance or achievements to differ materially. Please refer to our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
Non-GAAP Net Income attributable to
| Condensed Consolidated Statements of Income | |||||||||||||||
| (in thousands, except per share amounts) | |||||||||||||||
| (Unaudited) | |||||||||||||||
| Three Months Ended | |||||||||||||||
| 2025 | 2024 | 2024 | |||||||||||||
| Revenue | $ | 212,138 | $ | 222,628 | $ | 216,334 | |||||||||
| Cost of goods sold | 136,603 | 140,326 | 137,079 | ||||||||||||
| Gross Profit | 75,535 | 82,302 | 79,255 | ||||||||||||
| Gross margin % | 35.6 | % | 37.0 | % | 36.6 | % | |||||||||
| Operating Expenses: | |||||||||||||||
| Selling, general and administrative | 19,101 | 21,008 | 18,321 | ||||||||||||
| Research and development | 4,257 | 5,285 | 3,445 | ||||||||||||
| Total Operating Expenses | 23,358 | 26,293 | 21,766 | ||||||||||||
| Other operating (loss) gain | - | (182 | ) | - | |||||||||||
| Operating Income | 52,177 | 55,827 | 57,489 | ||||||||||||
| Operating Margin | 24.6 | % | 25.1 | % | 26.6 | % | |||||||||
| Non-operating (loss) income, net | 24,981 | (1,034 | ) | (3,747 | ) | ||||||||||
| Income Before Income Tax Provision | 77,158 | 54,793 | 53,742 | ||||||||||||
| Income tax provision | 18,901 | 14,568 | 14,660 | ||||||||||||
| Net Income | 58,257 | 40,225 | 39,082 | ||||||||||||
| Net income attributable to noncontrolling interests | 15,406 | 6,356 | 12,902 | ||||||||||||
| Net income attributable to |
$ | 42,851 | $ | 33,869 | $ | 26,180 | |||||||||
| Earnings per share attributed to |
|||||||||||||||
| Basic | $ | 0.69 | $ | 0.55 | $ | 0.43 | |||||||||
| Diluted | $ | 0.68 | $ | 0.54 | $ | 0.42 | |||||||||
| Weighted-average number of common shares outstanding: | |||||||||||||||
| Basic | 62,093 | 61,863 | 61,455 | ||||||||||||
| Diluted | 62,661 | 62,456 | 62,283 | ||||||||||||
| Condensed Consolidated Balance Sheets | ||||||||||
| (in thousands) | ||||||||||
| (Unaudited) | ||||||||||
| 2025 | 2024 | |||||||||
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 642,200 | $ | 598,485 | ||||||
| Short-term investments | - | 42,184 | ||||||||
| Accounts receivable | 188,438 | 200,830 | ||||||||
| Inventories | 57,583 | 56,527 | ||||||||
| Other current assets | 32,613 | 33,036 | ||||||||
| Total current assets | 920,834 | 931,062 | ||||||||
| Property, plant and equipment, net | 749,809 | 745,257 | ||||||||
| Other assets | 34,028 | 35,740 | ||||||||
| Total assets | $ | 1,704,671 | $ | 1,712,059 | ||||||
| Liabilities and Equity | ||||||||||
| Current liabilities: | ||||||||||
| Current portion of long-term debt | $ | 2,631 | $ | 17,972 | ||||||
| Accounts payable and accrued liabilities | 160,012 | 165,839 | ||||||||
| Total current liabilities | 162,643 | 183,811 | ||||||||
| Long-term debt | 21 | 25 | ||||||||
| Other liabilities | 47,798 | 47,464 | ||||||||
| Equity: | ||||||||||
| 1,127,749 | 1,120,864 | |||||||||
| Noncontrolling interests | 366,460 | 359,895 | ||||||||
| Total equity | 1,494,209 | 1,480,759 | ||||||||
| Total liabilities and equity | $ | 1,704,671 | $ | 1,712,059 | ||||||
| Condensed Consolidated Statements of Cash Flows | |||||||||||||
| (in thousands) | |||||||||||||
| (Unaudited) | |||||||||||||
| Three Months Ended | |||||||||||||
| 2025 | 2024 | ||||||||||||
| Cash flows from operating activities: | |||||||||||||
| Net income | $ | 58,257 | $ | 39,082 | |||||||||
| Adjustments to reconcile net income to net cash | |||||||||||||
| provided by operating activities: | |||||||||||||
| Depreciation and amortization | 20,792 | 20,702 | |||||||||||
| Share-based compensation | 3,334 | 2,573 | |||||||||||
| Changes in operating assets, liabilities and other | (3,917 | ) | (20,849 | ) | |||||||||
| Net cash provided by operating activities | 78,466 | 41,508 | |||||||||||
| Cash flows from investing activities: | |||||||||||||
| Purchases of property, plant and equipment | (35,200 | ) | (43,314 | ) | |||||||||
| Purchases of short-term investments | - | (2,436 | ) | ||||||||||
| Proceeds from maturities of short-term investments | 41,482 | 2,500 | |||||||||||
| Government incentives | 620 | 1,091 | |||||||||||
| Other | (57 | ) | (56 | ) | |||||||||
| Net cash provided by (used in) investing activities | 6,845 | (42,215 | ) | ||||||||||
| Cash flows from financing activities: | |||||||||||||
| Repayments of debt | (15,343 | ) | (1,194 | ) | |||||||||
| Common stock repurchases | (4,573 | ) | - | ||||||||||
| Proceeds from share-based arrangements | 1,433 | 936 | |||||||||||
| Net settlements of restricted stock awards | (1,995 | ) | (2,613 | ) | |||||||||
| Net cash used in financing activities | (20,478 | ) | (2,871 | ) | |||||||||
| Effects of exchange rate changes on cash, cash equivalents, and restricted cash | (21,202 | ) | 13,026 | ||||||||||
| Net increase in cash, cash equivalents, and restricted cash | 43,631 | 9,448 | |||||||||||
| Cash, cash equivalents, and restricted cash, beginning of period | 601,243 | 501,867 | |||||||||||
| Cash, cash equivalents, and restricted cash, end of period | $ | 644,874 | $ | 511,315 | |||||||||
| Reconciliation of GAAP Net income and Earnings per Share attributable to |
||||||||||||
| (in thousands, except per share amounts) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three Months ended | ||||||||||||
| 2025 | 2024 | 2024 | ||||||||||
| GAAP Net income attributable to |
$ | 42,851 | $ | 33,869 | $ | 26,180 | ||||||
| FX (gain) loss | (18,443 | ) | 7,758 | 8,909 | ||||||||
| Estimated tax effects of FX (gain) loss | 5,152 | (1,936 | ) | (2,244 | ) | |||||||
| Estimated noncontrolling interest effects of above | 2,823 | (2,637 | ) | (2,939 | ) | |||||||
| Non-GAAP Net income attributable to |
$ | 32,383 | $ | 37,054 | $ | 29,906 | ||||||
| Weighted-average number of common shares outstanding - Diluted | 62,661 | 62,456 | 62,283 | |||||||||
| GAAP Diluted earnings per share attributable to |
$ | 0.68 | $ | 0.54 | $ | 0.42 | ||||||
| Effects of non-GAAP adjustments above | (0.16 | ) | 0.05 | 0.06 | ||||||||
| Non-GAAP Diluted earnings per share attributable to |
$ | 0.52 | $ | 0.59 | $ | 0.48 | ||||||
For Further Information:
VP, Investor Relations
469.395.8175
tmoreau@photronics.com
Source: Photronics, Inc.




